Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine — Telemalrares

Skin Disease Clinical Trial

Official title:
Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine

Status Completed

Clinical Trial Summary

The investigators want to demonstrate that a new organization with telemedicine could rationalize the treatment pathway of patient suffering from rare skin disease. A diagnosis and a personalised treatment pathway could be performed before the consultation in the hospital.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02465476
Study type	Interventional
Source	University Hospital, Toulouse
Contact
Status	Completed
Phase	N/A
Start date	January 6, 2015
Completion date	May 30, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02663921` - Visible Light Study	N/A
Recruiting	`NCT01012453` - A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema	N/A
Not yet recruiting	`NCT05561595` - Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma	N/A
Completed	`NCT00910260` - Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels	Phase 4
Completed	`NCT02309905` - Evaluation of Tele-expertise for Inmates With a Dermatological Lesion	N/A
Completed	`NCT02338076` - A Study to Document the Effect of Petrolatum on Innate Immune Responses in the Skin	N/A
Completed	`NCT00001648` - Structure of the Herpes Simplex Virus Receptor	N/A
Completed	`NCT01187732` - Washing Without Water: Cost-effectiveness of a Rapidly Spreading Nursing Intervention in Bedridden Patients'	N/A